These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24124777)

  • 1. Neuropsychological syndromes in multiple sclerosis.
    Gil Moreno MJ; Cerezo García M; Marasescu R; Pinel González A; López Álvarez L; Aladro Benito Y
    Psicothema; 2013; 25(4):452-60. PubMed ID: 24124777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
    Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
    Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.
    Tur C; Penny S; Khaleeli Z; Altmann DR; Cipolotti L; Ron M; Thompson AJ; Ciccarelli O
    Mult Scler; 2011 Nov; 17(11):1324-32. PubMed ID: 21803874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis].
    Aldrete Cortez VR; Duriez-Sotelo E; Carrillo-Mora P; Pérez-Zuno JA
    Neurologia; 2013 Sep; 28(7):394-9. PubMed ID: 23260448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brain atrophy and cognitive disorder in multiple sclerosis].
    Pál E; Kosztolányi P; Perlaky P
    Orv Hetil; 2002 Dec; 143(48):2681-5. PubMed ID: 12501577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue.
    Lund H; Jønsson A; Andresen J; Rostrup E; Paulson OB; Sørensen PS
    Acta Neurol Scand; 2012 May; 125(5):338-44. PubMed ID: 21793807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures--an explorative study.
    Filippi M; Riccitelli G; Mattioli F; Capra R; Stampatori C; Pagani E; Valsasina P; Copetti M; Falini A; Comi G; Rocca MA
    Radiology; 2012 Mar; 262(3):932-40. PubMed ID: 22357892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume.
    Karlińska I; Siger M; Lewańska M; Selmaj K
    Neurol Neurochir Pol; 2008; 42(5):416-23. PubMed ID: 19105110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropsychological profile of multiple sclerosis].
    Arango-Lasprilla JC; DeLuca J; Chiaravalloti N
    Psicothema; 2007 Feb; 19(1):1-6. PubMed ID: 17295976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
    Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
    Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
    Ukkonen M; Vahvelainen T; Hämäläinen P; Dastidar P; Elovaara I
    Mult Scler; 2009 Sep; 15(9):1055-61. PubMed ID: 19556313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes.
    Amato MP; Hakiki B; Goretti B; Rossi F; Stromillo ML; Giorgio A; Roscio M; Ghezzi A; Guidi L; Bartolozzi ML; Portaccio E; De Stefano N;
    Neurology; 2012 Jan; 78(5):309-14. PubMed ID: 22262744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.
    Kincses ZT; Ropele S; Jenkinson M; Khalil M; Petrovic K; Loitfelder M; Langkammer C; Aspeck E; Wallner-Blazek M; Fuchs S; Jehna M; Schmidt R; Vécsei L; Fazekas F; Enzinger C
    Mult Scler; 2011 Jun; 17(6):681-9. PubMed ID: 21177325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.